Literature DB >> 16539539

MHCPred 2.0: an updated quantitative T-cell epitope prediction server.

Pingping Guan1, Channa K Hattotuwagama, Irini A Doytchinova, Darren R Flower.   

Abstract

UNLABELLED: The accurate computational prediction of T-cell epitopes can greatly reduce the experimental overhead implicit in candidate epitope identification within genomic sequences. In this article we present MHCPred 2.0, an enhanced version of our online, quantitative T-cell epitope prediction server. The previous version of MHCPred included mostly alleles from the human leukocyte antigen A (HLA-A) locus. In MHCPred 2.0, mouse models are added and computational constraints removed. Currently the server includes 11 human HLA class I, three human HLA class II, and three mouse class I models. Additionally, a binding model for the human transporter associated with antigen processing (TAP) is incorporated into the new MHCPred. A tool for the design of heteroclitic peptides is also included within the server. To refine the veracity of binding affinities prediction, a confidence percentage is also now calculated for each peptide predicted. AVAILABILITY: As previously, MHCPred 2.0 is freely available at the URL http://www.jenner.ac.uk/MHCPred/ CONTACT: Darren R. Flower (darren.flower@jenner.ac.uk).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16539539     DOI: 10.2165/00822942-200605010-00008

Source DB:  PubMed          Journal:  Appl Bioinformatics        ISSN: 1175-5636


  19 in total

1.  A modular concept of HLA for comprehensive peptide binding prediction.

Authors:  David S DeLuca; Barbara Khattab; Rainer Blasczyk
Journal:  Immunogenetics       Date:  2006-11-22       Impact factor: 2.846

2.  Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines.

Authors:  Raja Mazumder; Zhang-Zhi Hu; C R Vinayaka; Jose-Luis Sagripanti; Simon D W Frost; Sergei L Kosakovsky Pond; Cathy H Wu
Journal:  Virus Genes       Date:  2007-05-17       Impact factor: 2.332

Review 3.  Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of concept.

Authors:  Megan M O'Meara; Mary L Disis
Journal:  OMICS       Date:  2011-07-06

Review 4.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

5.  Design of a Multi-Epitopes Based Chimeric Vaccine against Enterobacter cloacae Using Pan-Genome and Reverse Vaccinology Approaches.

Authors:  Wafa Abdullah I Al-Megrin; Alaa Karkashan; Abdullah M Alnuqaydan; Faris F Aba Alkhayl; Faris Alrumaihi; Ahmad Almatroudi; Khaled S Allemailem
Journal:  Vaccines (Basel)       Date:  2022-06-01

Review 6.  Antigen-specific vaccines for cancer treatment.

Authors:  Maria Tagliamonte; Annacarmen Petrizzo; Maria Lina Tornesello; Franco M Buonaguro; Luigi Buonaguro
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica.

Authors:  Patricia A Nelson; Mojgan Khodadoust; Thomas Prodhomme; Collin Spencer; Juan Carlos Patarroyo; Michel Varrin-Doyer; Joseph D Ho; Robert M Stroud; Scott S Zamvil
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 8.  Immunogenicity of Protein Pharmaceuticals.

Authors:  Robert Dingman; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2018-12-30       Impact factor: 3.534

9.  Prediction and characterization of T-cell epitopes for epitope vaccine design from outer membrane protein of Neisseria meningitidis serogroup B.

Authors:  Sharat Chandra; Digvijay Singh; Tiratha Raj Singh
Journal:  Bioinformation       Date:  2010-09-20

10.  Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research.

Authors:  Hong Huang Lin; Guang Lan Zhang; Songsak Tongchusak; Ellis L Reinherz; Vladimir Brusic
Journal:  BMC Bioinformatics       Date:  2008-12-12       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.